Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
María Torres-Durán, José Luis López-Campos, Myriam Calle Rubio, Carmen Montero-Martínez, Ana Priegue Carrera, Rosanel Amaro Rodríguez, Miriam Barrecheguren, María Ángeles Barrio Guirado, Francisco Javier Callejas-González, Francisco Casas-Maldonado, Layla Diab-Cáceres, Pilar García-Meseguer, José María Hernández-Pérez, Lourdes Lázaro-Asegurado, Cristina Martínez-González, Carlos Martínez Rivera, Francisco Javier Michel, José-Bruno Montoro-Ronsano, Raquel Sánchez, Marta Ortiz-Pica, Isabel Parra, José Pablo Quintero García, María del Rosario Ruiz-Serrano-de la Espada, Begoña Tortajada-Goitia & Marc Miravitlles. (2023) Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1691-1700.
Read now
Read now
Michael Newnham, Mark Quinn & Alice M Turner. (2023) Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1197-1205.
Read now
Read now
Oisín F. McElvaney, Daniel D. Fraughen, Oliver J. McElvaney, Tomás P. Carroll & Noel G. McElvaney. (2023) Alpha-1 antitrypsin deficiency: current therapy and emerging targets. Expert Review of Respiratory Medicine 17:3, pages 191-202.
Read now
Read now
Weichang Yang, Fengyuan Li, Can Li, Jiaqi Meng & Ying Wang. (2021) Focus on Early COPD: Definition and Early Lung Development. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3217-3228.
Read now
Read now
Anita Pye, Sheeba Khan, Tony Whitehouse & Alice M Turner. (2021) Personalizing liver targeted treatments and transplantation for patients with alpha-1 antitrypsin deficiency. Expert Review of Precision Medicine and Drug Development 6:1, pages 65-78.
Read now
Read now
Mark Quinn, Paul Ellis, Anita Pye & Alice M Turner. (2020) Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives. Therapeutics and Clinical Risk Management 16, pages 1243-1255.
Read now
Read now
Marc Miravitlles, Alexa Nuñez, Maria Torres-Durán, Francisco Casas-Maldonado, Juan Luis Rodríguez-Hermosa, José Luis López-Campos, Myriam Calle, Esther Rodríguez, Cristina Esquinas & Miriam Barrecheguren. (2020) The Importance of Reference Centers and Registries for Rare Diseases: The Example of Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:4, pages 346-354.
Read now
Read now
Kylie B R Belchamber, Eloise M Walker, Robert A Stockley & Elizabeth Sapey. (2020) Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3183-3192.
Read now
Read now
Anita Pye & Alice M Turner. (2019) Experimental and investigational drugs for the treatment of alpha-1 antitrypsin deficiency. Expert Opinion on Investigational Drugs 28:10, pages 891-902.
Read now
Read now
Priya S Chukowry, Ross Gareth Edgar & Alice M Turner. (2019) Alpha 1 antitrypsin deficiency: a rare multisystem disease, predominantly affecting the lung. Expert Opinion on Orphan Drugs 7:7-8, pages 315-326.
Read now
Read now
Jeanne Marie Perotin, Sylvie Leroy, Charles Hugo Marquette, Hervé Mal, Hervé Dutau, Arnaud Bourdin, Jean Michel Vergnon, Christophe Pison, Coralie Barbe & Gaëtan Deslee. (2018) Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3645-3649.
Read now
Read now
Behrouz Mostafavi, Sandra Diaz, Eeva Piitulainen, Berend C Stoel, Per Wollmer & Hanan A Tanash. (2018) Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3689-3698.
Read now
Read now
Diana Crossley, Mary Renton, Muhammad Khan, Emma V Low & Alice M Turner. (2018) CT densitometry in emphysema: a systematic review of its clinical utility. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 547-563.
Read now
Read now
Articles from other publishers (36)
Stephen G. J. Smith & Catherine M. Greene. (2023) Long Non-Coding RNA Expression in Alpha-1 Antitrypsin Deficient Monocytes Pre- and Post-AAT Augmentation Therapy. Non-Coding RNA 9:1, pages 6.
Crossref
Crossref
J.-F. Mornex. (2022) Le déficit en alpha 1-antitrypsine. Revue des Maladies Respiratoires 39:8, pages 698-707.
Crossref
Crossref
J.-F. Mornex, M. Balduyck, M. Bouchecareilh, A. Cuvelier, R. Epaud, M. Kerjouan, O. Le Rouzic, C. Pison, L. Plantier, M.-C. Pujazon, M. Reynaud-Gaubert, A. Toutain, B. Trumbic, M.-C. Willemin, M. Zysman, O. Brun, M. Campana, F. Chabot, V. Chamouard, M. Dechomet, J. Fauve, B. Girerd, C. Gnakamene, S. Lefrançois, J.-N. Lombard, B. Maitre, C. Maynié-François, A. Moerman, A. Payancé, P. Reix, D. Revel, M.-P. Revel, M. Schuers, P. Terrioux, D. Theron, F. Willersinn, V. Cottin & H. Mal. (2022) Atteinte pulmonaire du déficit en alpha-1 antitrypsine. Recommandations pratiques pour le diagnostic et la prise en charge. Revue des Maladies Respiratoires 39:7, pages 633-656.
Crossref
Crossref
Parvarish Sharma, Daljeet Singh Dhanjal, Chirag Chopra, Murtaza M. Tambuwala, Sukhwinder Singh Sohal, Peter J. van der Spek, Hari S. Sharma & Saurabh Satija. (2022) Targeting eosinophils in chronic respiratory diseases using nanotechnology-based drug delivery. Chemico-Biological Interactions 365, pages 110050.
Crossref
Crossref
Yu Fu, Emma J Chapman, Alison C Boland & Michael I Bennett. (2022) Evidence-based management approaches for patients with severe chronic obstructive pulmonary disease (COPD): A practice review. Palliative Medicine 36:5, pages 770-782.
Crossref
Crossref
Jacob Colello, Anna Ptasinski, Xiang Zhan, Sundeep Kaur & Timothy Craig. (2022) Assessment of Patient Perspectives and Barriers to Self-Infusion of Augmentation Therapy for Alpha-1 Antitrypsin Deficiency During the COVID-19 Pandemic. Pulmonary Therapy 8:1, pages 95-103.
Crossref
Crossref
Emanuel Buck, Maria Ada Presotto, Judith Brock, Kai Schlamp, Martina Veith, Felix J.F. Herth & Franziska Christina Trudzinski. (2022) Augmentation therapy with human alpha-1-proteinase inhibitor reduces exacerbations in patient with bronchiectasis and alpha-1-antitrypsin deficiency. Respiratory Medicine Case Reports 39, pages 101740.
Crossref
Crossref
Francisco J. Padilla-Godínez, Rodrigo Ramos-Acevedo, Hilda Angélica Martínez-Becerril, Luis D. Bernal-Conde, Jerónimo F. Garrido-Figueroa, Marcia Hiriart, Adriana Hernández-López, Rubén Argüero-Sánchez, Francesco Callea & Magdalena Guerra-Crespo. (2021) Protein Misfolding and Aggregation: The Relatedness between Parkinson’s Disease and Hepatic Endoplasmic Reticulum Storage Disorders. International Journal of Molecular Sciences 22:22, pages 12467.
Crossref
Crossref
Josiah D Murray, Maria A Willrich, Michael J Krowka, Aleh Bobr, David L Murray, Kevin C Halling, Rondell P Graham & Melissa R Snyder. (2021) Liquid Chromatography–Tandem Mass Spectrometry–Based α1-Antitrypsin (AAT) Testing. American Journal of Clinical Pathology 155:4, pages 547-552.
Crossref
Crossref
Mark Quinn, Alice Margaret Turner & Ravi Mahadeva. (2021) Unravelling the risk of (intermediate) antitrypsin deficiency. Thorax 76:3, pages 214-215.
Crossref
Crossref
Uday K Baliga & David A Dean. (2020) Pulmonary gene delivery—Realities and possibilities. Experimental Biology and Medicine 246:3, pages 260-274.
Crossref
Crossref
Jen-hwa Chu, Wenlan Zang, Milica Vukmirovic, Xiting Yan, Taylor Adams, Giuseppe DeIuliis, Buqu Hu, Antun Mihaljinec, Jonas C Schupp, Michael J Becich, Harry Hochheiser, Kevin F Gibson, Edward S Chen, Alison Morris, Joseph K Leader, Stephen R Wisniewski, Yingze Zhang, Frank C Sciurba, Ronald G Collman, Robert Sandhaus, Erica L Herzog, Karen C Patterson, Maor Sauler, Charlie Strange & Naftali Kaminski. (2021) Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency. Thorax 76:2, pages 134-143.
Crossref
Crossref
Igor Barjaktarevic & Michael Campos. (2021) Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know. Therapeutic Advances in Chronic Disease 12_suppl, pages 204062232110101.
Crossref
Crossref
İlkay S. İdilman, Deniz Akata & Muşturay Karçaaltıncaba. 2021. Imaging of the Liver and Intra-hepatic Biliary Tract. Imaging of the Liver and Intra-hepatic Biliary Tract
241
249
.
Mario Cazzola, Daiana Stolz, Paola Rogliani & Maria Gabriella Matera. (2020)
α
1
-Antitrypsin deficiency and chronic respiratory disorders
. European Respiratory Review 29:155, pages 190073.
Crossref
Crossref
Jack Dummer, Claudia C. Dobler, Mark Holmes, Daniel Chambers, Ian A. Yang, Lianne Parkin, Sheree Smith, Peter Wark, Anouk Dev, Sandra Hodge, Eli Dabscheck, Julian Gooi, Sameh Samuel, Steven Knowles & Anne E. Holland. (2020) Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand*. Respirology 25:3, pages 321-335.
Crossref
Crossref
Paul Ellis & Alice Turner. (2020) What Do Alpha-1 Antitrypsin Levels Tell Us About Chronic Inflammation in COPD?. Archivos de Bronconeumología 56:2, pages 72-73.
Crossref
Crossref
Paul Ellis & Alice Turner. (2020) What Do Alpha-1 Antitrypsin Levels Tell Us About Chronic Inflammation in COPD?. Archivos de Bronconeumología (English Edition) 56:2, pages 72-73.
Crossref
Crossref
Zoya Awan & Alice Turner. 2020. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
377
389
.
Martin H. Schöni. 2020. Pädiatrie. Pädiatrie
1867
1870
.
Jonathan A. Kropski. 2020. Precision in Pulmonary, Critical Care, and Sleep Medicine. Precision in Pulmonary, Critical Care, and Sleep Medicine
11
23
.
Franck Rahaghi, Laurel Omert, Virginia Clark & Robert A. Sandhaus. (2019) Managing the Alpha-1 patient in the ICU: Adapting broad critical care strategies in AATD. Journal of Critical Care 54, pages 212-219.
Crossref
Crossref
Miriam Barrecheguren & Marc Miravitlles. (2019) Treatment with inhaled α1-antitrypsin: a square peg in a round hole?. European Respiratory Journal 54:5, pages 1901894.
Crossref
Crossref
Paul Ellis, Asger Dirksen & Alice M. Turner. 2019.
α
1
-Antitrypsin Deficiency
.
α
1
-Antitrypsin Deficiency
78
92
.
Diana Crossley, Robert Stockley & Elizabeth Sapey. (2019) Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?. Drugs & Aging 36:9, pages 823-840.
Crossref
Crossref
Ildikó Horváth, Maria Canotilho, Jan Chlumský, Joanna Chorostowska-Wynimko, Luciano Corda, Eric Derom, Joachim H. Ficker, Meinhard Kneussl, Marc Miravitlles, Maria Sucena, Gabriel Thabut, Alice M. Turner, Emily van ’t Wout & N. Gerard McElvaney. (2019)
Diagnosis and management of α
1
-antitrypsin deficiency in Europe: an expert survey
. ERJ Open Research 5:1, pages 00171-2018.
Crossref
Crossref
Gema Mondejar-Parreño, María Callejo, Angel Cogolludo & Francisco Pérez-Vizcaíno. 2019. Nucleic Acid Nanotheranostics. Nucleic Acid Nanotheranostics
89
131
.
Martin H. Schöni. 2019. Pädiatrie. Pädiatrie
1
4
.
Karin F. Hoth & Elizabeth Kozora. 2019. Handbook on the Neuropsychology of Aging and Dementia. Handbook on the Neuropsychology of Aging and Dementia
661
674
.
Timothy J. Craig & Maria Paula Henao. (2018)
Advances in managing COPD related to α
1
-antitrypsin deficiency: An under-recognized genetic disorder
. Allergy 73:11, pages 2110-2121.
Crossref
Crossref
Gustavo Ortiz, Emiliano S. Lopez, Juan P. Salica, Constanza Potilinski, Mariano Fernández Acquier, Eduardo Chuluyan & Juan E. Gallo. (2018) Alpha-1-antitrypsin ameliorates inflammation and neurodegeneration in the diabetic mouse retina. Experimental Eye Research 174, pages 29-39.
Crossref
Crossref
Alice M. Turner, Jan Stolk, Robert Bals, Jason D. Lickliter, James Hamilton, Dawn R. Christianson, Bruce D. Given, Jonathan G. Burdon, Rohit Loomba, James K. Stoller & Jeffery H. Teckman. (2018) Hepatic-targeted RNA interference provides robust and persistent knockdown of alpha-1 antitrypsin levels in ZZ patients. Journal of Hepatology 69:2, pages 378-384.
Crossref
Crossref
David Z. Silberstein, Kalimuthu Karuppanan, Hnin Hnin Aung, Ching-Hsien Chen, Carroll E. Cross & Karen A. McDonald. (2018) An oxidation-resistant, recombinant alpha-1 antitrypsin produced in Nicotiana benthamiana. Free Radical Biology and Medicine 120, pages 303-310.
Crossref
Crossref
S. A. Townsend, R. G. Edgar, P. R. Ellis, D. Kantas, P. N. Newsome & A. M. Turner. (2018) Systematic review: the natural history of alpha-1 antitrypsin deficiency, and associated liver disease. Alimentary Pharmacology & Therapeutics 47:7, pages 877-885.
Crossref
Crossref
Haitham S. Al Ashry & Charlie Strange. (2017) COPD in individuals with the PiMZ alpha-1 antitrypsin genotype. European Respiratory Review 26:146, pages 170068.
Crossref
Crossref
Dieter Köhler. (2017) Alpha-1-Antitrypsin-Mangel: Ist die Substitution ein Mythos?. Deutsches Ärzteblatt Online.
Crossref
Crossref